MG2 and Ardena together for a in-depth webinar
Read the ITALIAN version
The partnership with the belgian CDMO Ardena continues.
As demonstration of this closer cooperation, on June 7th at 16:00 CET we will host a webinar entitled “Capsules, a versatile OSD for early phase development”.
It will be presented by Mr Marco Bellentani, MG2 Product and Validation Manager, and Mrs Giulia Milanesi, Ardena Senior Scientist who will:
- explain the essential aspects of oral solid forms development
- compare tablets vs capsules to help you choose the best dosage form for your drug
- cover the critical process aspects from early phase to larger scale manufacturing